Redefining dose-limiting toxicity
Clin Adv Hematol Oncol
.
2015 Feb;13(2):87-9.
Author
Sophie Postel-Vinay
1
Affiliation
1
Institute Gustave Roussy, Villejuif, France.
PMID:
25774476
No abstract available
Publication types
Interview
MeSH terms
Antineoplastic Agents / administration & dosage
Antineoplastic Agents / adverse effects*
Dose-Response Relationship, Drug
Humans
Maximum Tolerated Dose*
Neoplasms / drug therapy*
Substances
Antineoplastic Agents